Abstract:Journal of Digestive DiseasesEarly View LETTER TO THE EDITOR Transient hepatic portal venous gas secondary to acute ischemic necrotic colitis in a lymphoma patient during chemotherapy: A case report and review Min Yue Zhang, Min Yue Zhang orcid.org/0000-0002-3393-215X Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorFei Xiao, Fei Xiao Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorXiao Feng Han, Xiao Feng Han Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorJian Hou, Jian Hou Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorHong Xia Gong, Hong Xia Gong Division of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorYan Ying Shen, Yan Ying Shen Division of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorHong Hui Huang, Corresponding Author Hong Hui Huang [email protected] Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China Correspondence Hong Hui Huang, Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai 200127, China. Email: [email protected]Search for more papers by this author Min Yue Zhang, Min Yue Zhang orcid.org/0000-0002-3393-215X Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorFei Xiao, Fei Xiao Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorXiao Feng Han, Xiao Feng Han Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorJian Hou, Jian Hou Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorHong Xia Gong, Hong Xia Gong Division of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorYan Ying Shen, Yan Ying Shen Division of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, ChinaSearch for more papers by this authorHong Hui Huang, Corresponding Author Hong Hui Huang [email protected] Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China Correspondence Hong Hui Huang, Division of Hematology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai 200127, China. Email: [email protected]Search for more papers by this author First published: 28 July 2023 https://doi.org/10.1111/1751-2980.13212 Min Yue Zhang and Fei Xiao contributed equally to this work. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Peloponissios N, Halkic N, Pugnale M, et al. Hepatic portal gas in adults: review of the literature and presentation of a consecutive series of 11 cases. Arch Surg. 2003; 138(12): 1367-1370. 2Chung SM, Kim KH, Kim KO, Kim TN. Hepatobiliary and pancreatic: hepatic portal vein gas accompanied by acute enterocolitis improved with non-surgical treatment. J Gastroenterol Hepatol. 2017; 32(2): 294. 3Wolfe JN, Evans WA. Gas in the portal veins of the liver in infants; a roentgenographic demonstration with postmortem anatomical correlation. Am J Roentgenol Radium Ther Nucl Med. 1955; 74(3): 486-488. 4Hussain A, Mahmood H, El-Hasani S. Portal vein gas in emergency surgery. World J Emerg Surg. 2008; 3: 21. doi:10.1186/1749-7922-3-21 5Wayne E, Ough M, Wu A, et al. Management algorithm for pneumatosis intestinalis and portal venous gas: treatment and outcome of 88 consecutive cases. J Gastrointest Surg. 2010; 14(3): 437-448. 6Koami H, Isa T, Ishimine T, et al. Risk factors for bowel necrosis in patients with hepatic portal venous gas. Surg Today. 2015; 45(2): 156-161. 7Seak CJ, Yen DH, Ng CJ, et al. Rapid Emergency Medicine Score: a novel prognostic tool for predicting the outcomes of adult patients with hepatic portal venous gas in the emergency department. PLoS One. 2017; 12(9):e0184813. doi:10.1371/journal.pone.0184813 8Wang FF, Lyu SC, He Q. Research progress on etiology and mechanism of portal vein gas. Chin J Hepatobiliary Surg. 2021; 27(9): 717-720. [in Chinese]. 9Daneshmand A, Parys S, Rao S, Watanabe Y, Sieunarine K. Portal venous gas: different aetiologies and their respective outcomes. ANZ J Surg. 2020; 90(5): 767-771. 10Liu C, Wu CH, Zheng XD, et al. Hepatic portal venous gas: a case report and analysis of 131 patients using PUBMED and MEDLINE database. Am J Emerg Med. 2021; 45: 506-509. 11Kung D, Ruan DT, Chan RK, Ericsson ML, Saund MS. Pneumatosis intestinalis and portal venous gas without bowel ischemia in a patient treated with irinotecan and cisplatin. Dig Dis Sci. 2008; 53(1): 217-219. 12Zalinski S, Scatton O, Jacqmin S, Tacher V, Brézault C, Soubrane O. Portal venous gas following chemotherapy for colorectal cancer liver metastasis. Eur J Surg Oncol. 2009; 35(5): 557-560. 13Cassese G, Maione F, Alagia M, et al. Portal venous gas after a failed endoscopic retrograde cholangiopancreatography attempt in a patient with a large hepatocellular carcinoma: a case report. Clin Case Rep. 2021; 9(3): 1339-1343. 14Liang KW, Huang HH, Tyan YS, Tsao TF. Hepatic portal venous gas: review of ultrasonographic findings and the use of the “meteor shower” sign to diagnose it. Ultrasound Q. 2018; 34(4): 268-271. 15Schindera ST, Triller J, Vock P, Hoppe H. Detection of hepatic portal venous gas: its clinical impact and outcome. Emerg Radiol. 2006; 12(4): 164-170. 16Nelson AL, Millington TM, Sahani D, et al. Hepatic portal venous gas: the ABCs of management. Arch Surg. 2009; 144(6): 575-581. 17Kinoshita H, Shinozaki M, Tanimura H, et al. Clinical features and management of hepatic portal venous gas: four case reports and cumulative review of the literature. Arch Surg. 2001; 136(12): 1410-1414. 18Gonda M, Osuga T, Ikura Y, Hasegawa K, Kawasaki K, Nakashima T. Optimal treatment strategies for hepatic portal venous gas: a retrospective assessment. World J Gastroenterol. 2020; 26(14): 1628-1637. 19Maimone A, De Ceglie A, Siersema PD, Baron TH, Conio M. Colon ischemia: a comprehensive review. Clin Res Hepatol Gastroenterol. 2021; 45(6):101592. doi:10.1016/j.clinre.2020.101592 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation

Abstract:We read the paper “Novel classification of non-malignant portal vein thrombosis: A guide to surgical decision-making during liver transplantation” with great interest.[1]Bhangui P. Lim C. Levesque E. Salloum C. Lahat E. Feray C. et al.Novel classification of non-malignant portal vein thrombosis: a guide to surgical decision-making during liver transplantation.J Hepatol. 2019; 71: 1038-1050Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar This is an excellent and inspiring study proposing a new tailored classification of non-tumoral portal vein thrombosis (PVT) in candidates for liver transplantation (LT), incorporating anatomic and functional parameters (collateral circulations). In the novel classification system of non-malignant PVT proposed by Prashant Bhangui et al., PVT was dichotomised into non-complex (Yerdel grade 1-3) and complex PVT (Yerdel grade 4).[1]Bhangui P. Lim C. Levesque E. Salloum C. Lahat E. Feray C. et al.Novel classification of non-malignant portal vein thrombosis: a guide to surgical decision-making during liver transplantation.J Hepatol. 2019; 71: 1038-1050Abstract Full Text Full Text PDF PubMed Scopus (41) Google Scholar The portal inflow reconstruction can be classified as physiological or non-physiological based on whether it could solve the problem of pre-existing prehepatic portal hypertension (PHT). Physiological portal reconstruction drains the splanchnic blood flow to the graft, thus helping to ameliorate prehepatic portal hypertension after LT. Subsequently, even in those with complex PVT, the presence of remarkable portosystemic collaterals or shunts (splenorenal shunt, enlarged left gastric vein or pericholedochal varix) could also achieve physiological portal reconstruction.[2]Yang Z. Wang S. Lerut J. Zhuang L. Zheng S. Portal inflow reconstruction for liver transplantation with portal veinthrombosis.Hepatobiliary Surg Nutr. 2021; 10: 291-294Crossref PubMed Google Scholar The tailored surgical strategies for portal inflow reconstruction differ not only depending on the splanchnic vascular structures but also on hepatic hemodynamic changes. In whole-organ allografts, the portal vein flow (PVF) should be at least 1,000 ml/min to maintain adequate graft perfusion.[3]Spitzer A.L. Dick A.A. Bakthavatsalam R. Halldorson J.B. Sal- valaggio P.R. Reyes J.D. et al.Intraoperative portal vein blood flow predicts allograft and patient survival following liver transplantation.HPB (Oxford). 2010; 12: 166-173Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar,[4]Kim P.T. Fernandez H. Gupta A. Saracino G. Ramsay M. McKenna G.J. et al.Low measured hepatic artery flow increases rate of biliary strictures in deceased donor liver transplantation: an age-dependent phenomenon.Transplantation. 2017; 101: 332-340Crossref PubMed Scopus (20) Google Scholar In transplant recipients with remarkable collateral vessels, ligation of the major portal systemic shunts is essential if the PVF is <1,000 ml/min, in order to prevent portal flow steal.[5]Feng A.C. Fan H.L. Chen T.W. Hsieh C.B. Hepatic hemodynamic changes during liver transplantation: a review.World J Gastroenterol. 2014; 20: 11131-11141Crossref PubMed Scopus (38) Google Scholar Therefore, we are of the opinion that non-tumoral PVT can be categorized into five types according to the site, presence of patent collaterals and the graft hemodynamic status in the setting of LT (Fig. 1). The tailored classification strictly corresponds to patterns of PV inflow reconstruction and graft inflow modulation. In type I, PVT localizes above the confluence of the splenic vein and the superior mesenteric vein (SMV), without enlarged collaterals; in such cases anatomical porto-portal anastomosis without interruption of collaterals can be performed. In type II, PVT localizes above the confluence of the splenic vein and the SMV and presents with remarkable collaterals. Interruption of the collaterals is required if portal perfusion is <1,000 ml/min. In individuals with a surgically created portosystemic shunt, patent surgically created shunts should be dismantled intra-operatively. Additionally, in the presence of a splenorenal shunt, it is also feasible to ligate the left renal vein rather than the shunt itself because there are many collaterals in general. In type III, PVT extends below the confluence of the splenic vein and the SMV, but with a patent proximal SMV; in such cases the recipient SMV can still be used as the main portal influx source by interposing a vascular graft between the SMV and graft portal vein. This conduit is placed anterior to the pancreas and posterior to the pylorus. Interruption of the collaterals is required in the presence of a spontaneous splenorenal shunt or an enlarged gastric vein. Another surgical strategy for Type III PVT is thrombectomy with eversion followed by anatomical porto-portal anastomosis when feasible. In Type IV, PVT involves the whole SMV but with enlarged patent portosystemic shunts (either spontaneous or surgically created); these collateral vessels can be used as portal influx vessels, including renal (left renal vein), gastric (left gastric vein), peri-choledochal, and rarely dilated mesenteric vein tributaries, such as the right gastroepiploic and right and middle colic veins. In the presence of both an enlarged gastric vein and a splenorenal shunt, the prime surgical strategy is a portal inflow reconstruction using the enlarged gastric vein combined with the ligation of the left renal vein to avoid the steal phenomenon. When portal perfusion is <1,000 ml/min, a double anastomosis (such as a combined reno-portal and coronary-portal anastomosis) can be considered to ensure adequate portal inflow. In type V, PVT entails the complete thrombosis of both the porto-mesenteric and collateral veins; in such cases a non-physiological reconstruction can be considered, such as renoportal, cavoportal, portal vein arterialisation, multivisceral transplantation and heterotopic transplantation. Usually, porto-caval hemi-transposition is used to restore adequate portal flow. In some cases, a liver-intestinal transplant will be necessary to solve the problem. In this situation, the pre-existing prehepatic portal hypertension will not be solved and could even be worsened by liver transplantation. In conclusion, the proposed new categorization of PVT, incorporating the location of the splanchnic thrombosis, the extent of the collateral vessels and hemodynamic changes may allow for better preoperative planning and intraoperative tailoring of portal reconstruction and graft inflow modulation. This study was supported by the Research Project of Jinan Microecological Biomedicine Shandong Laboratory (JNL-2022016B) and the Natural Science Foundation of Zhejiang Province of China (Y21H160259). SS Zheng is the guarantor. Z Yang and SS Zheng designed the study and wrote the draft. J Lerut critically revised the manuscript and provided valuable comments. All authors approved the final version of the manuscript. The authors have no conflicts of interest to declare. Please refer to the accompanying ICMJE disclosure forms for further details. The following is the supplementary data to this article: Download .pdf (4.55 MB) Help with pdf files Multimedia component 1 Novel classification of non-malignant portal vein thrombosis: A guide to surgical decision-making during liver transplantationJournal of HepatologyVol. 71Issue 5PreviewNon-tumoral portal vein thrombosis (PVT) is present at liver transplantation in 5% to 26% of cirrhotic patients, and the prevalence of complex PVT as defined here (grade 4 Yerdel, and grade 3,4 Jamieson and Charco) has been reported in 0% to 2.2%. Adequate portal inflow is mandatory to ensure graft and patient survival after liver transplantation. With time, the proposed classifications of non-tumoral chronic PVT have evolved from being anatomy-based, to also incorporating functional parameters. Full-Text PDF

Nonmalignant Partial Portal Vein Thrombosis in Liver Cirrhosis: to Treat or Not to Treat?

Use of 8-Mm Covered TIPS: is “losses Without Gains” the End of the Story?

Degree of Portal Vein Thrombosis

Jaundice Constrain or Indication? Response.

Degree of Portal Vein Thrombosis Might Be Associated with Recanalization During Anticoagulation

Spontaneous Resolution of Portal Vein Thrombosis in Cirrhosis: Where Do We Stand, and Where Will We Go?

Transient hepatic portal venous gas secondary to acute ischemic necrotic colitis in a lymphoma patient during chemotherapy: A case report and review

Management of Portal vein Thrombosis in Cirrhosis

A Single Hospital Study on Portal Vein Thrombosis in Cirrhotic Patients - Clinical Characteristics & Risk Factors.

Transjugular Intrahepatic Portosystemic Shunt for Portal Vein Thrombosis with Symptomatic Portal Hypertension in Liver Cirrhosis

The portal hypertension syndrome: etiology, classification, relevance, and animal models

Diagnosis and treatment of acute portal vein thrombosis

Clinical Significance of Removal of Tumor Thrombi in the Main Portal Vein in Patients with Hepatocellular Carcinoma

The Reason and Treatment of Portal Vein Thrombosis in Patients with Portal Hypertension Postoperation

The Preferable Treatment for Cirrhotic Portal Vein Thrombosis: Anticoagulation or Transjugular Intrahepatic Portosystemic Shunt?

Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai)

Classification and Management of Portal Vein Thrombosis in Cirrhotic Patients: A Narrative Review

Is Radiotherapy the Best Option for Treating Hepatocellular Carcinoma with Portal Vein Tumour Thrombosis?

Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies.

Portal Vein Thrombosis: State-of-the-Art Review

Categorization of Differing Types of Non-Tumoral Portal Vein Thrombosis Based on the Location and Hemodynamic Changes During Liver Transplantation.